Denali Therapeutics Inc (DNLI)
18.56
+0.10
(+0.54%)
USD |
NASDAQ |
May 31, 16:00
18.59
+0.03
(+0.16%)
Pre-Market: 20:00
Denali Therapeutics 1 Year Total Returns (Daily): -38.58% for May 31, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 31, 2024 | -38.58% |
| May 30, 2024 | -36.93% |
| May 29, 2024 | -39.79% |
| May 28, 2024 | -36.92% |
| May 24, 2024 | -38.82% |
| May 23, 2024 | -39.74% |
| May 22, 2024 | -36.34% |
| May 21, 2024 | -36.73% |
| May 20, 2024 | -36.26% |
| May 17, 2024 | -31.04% |
| May 16, 2024 | -30.92% |
| May 15, 2024 | -34.85% |
| May 14, 2024 | -29.36% |
| May 13, 2024 | -30.97% |
| May 10, 2024 | -35.46% |
| May 09, 2024 | -31.66% |
| May 08, 2024 | -28.84% |
| May 07, 2024 | -36.46% |
| May 06, 2024 | -35.37% |
| May 03, 2024 | -33.72% |
| May 02, 2024 | -31.05% |
| May 01, 2024 | -37.36% |
| April 30, 2024 | -37.84% |
| April 29, 2024 | -37.20% |
| April 26, 2024 | -36.68% |
| Date | Value |
|---|---|
| April 25, 2024 | -37.38% |
| April 24, 2024 | -37.64% |
| April 23, 2024 | -35.87% |
| April 22, 2024 | -36.35% |
| April 19, 2024 | -35.95% |
| April 18, 2024 | -33.92% |
| April 17, 2024 | -34.14% |
| April 16, 2024 | -29.83% |
| April 15, 2024 | -27.80% |
| April 12, 2024 | -24.33% |
| April 11, 2024 | -19.59% |
| April 10, 2024 | -23.47% |
| April 09, 2024 | -19.93% |
| April 08, 2024 | -21.58% |
| April 05, 2024 | -19.58% |
| April 04, 2024 | -19.74% |
| April 03, 2024 | -17.12% |
| April 02, 2024 | -15.89% |
| April 01, 2024 | -10.76% |
| March 28, 2024 | -10.08% |
| March 27, 2024 | -10.74% |
| March 26, 2024 | -13.19% |
| March 25, 2024 | -13.23% |
| March 22, 2024 | -13.11% |
| March 21, 2024 | -9.72% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-71.45%
Minimum
Jun 14 2022
395.9%
Maximum
Dec 30 2020
25.72%
Average
-11.54%
Median
Jan 31 2023
1 Year Total Returns (Daily) Benchmarks
| Halozyme Therapeutics Inc | 36.66% |
| Neurocrine Biosciences Inc | 51.25% |
| AIM ImmunoTech Inc | -21.93% |
| Protalix BioTherapeutics Inc | -45.93% |
| Armata Pharmaceuticals Inc | 103.0% |